MarketInOut Stock Screener Log In | Sign Up
 

Beta Bionics Inc

IEX • Healthcare • Medical Devices • Quote as of 09/18/2026
Beta Bionics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization936.24 mln
Float44.78 mln
Earnings Date11/03/2026

Beneish M-Score

-2.34
Borderline

1-Year Forecast

22.40
Fairly priced

Relative Strength

96 / 100
Top performer

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-61%
Severely loss-making

ROE

-25.85
Deeply negative

Business Description

Beta Bionics makes medical devices that help people with diabetes manage their insulin automatically. Its main product, the iLet Bionic Pancreas, handles insulin delivery on its own for adults and children as young as six, removing much of the daily burden of managing type 1 diabetes. The company is working on several next-generation products, including a tubeless patch pump and a device that delivers both insulin and glucagon together. Founded in 2015 and based in Irvine, California, Beta Bionics works alongside Abbott Diabetes Care and Xeris Pharmaceuticals to bring these solutions to market.

Key Fundamentals

EPS-1.60
ROE-25.85
RPS2.69
ROIC-95.16
ROA-23.01
EBITDA, mln-77.22
EV / EBITDA-9.23
EV / EBIT-9.04
Revenue, mln119
EV / Revenue5.99

Quote Details

Last 21.89
Change 0.46 (2.15%)
Open 21.30
Volume 877,608
Turnover 19,210,838
Average Volume 1,127,851

Financial Ratios

Pre-Tax Profit Margin-61
Leverage Ratio1.14
Current Ratio8.88
Price / Book3.46
Price / Tangible Book3.46
Debt / Equity0.03
Price / Sales7.32

Financial Strength

Altman Z-Score13.2
Beneish M-Score-2.34
1-Year Target Price22.40
Short Ratio7.49
Short % of Float20.99

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 32.11% 99 / 100   
1 Month 9.4% 93 / 100   
2 Months 49.01% 97 / 100   
6 Months 106% 98 / 100   
1 Year -6.01% 39 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us